25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?

Erin D. Michos, Pamela L. Lutsey

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)237-239
Number of pages3
JournalAtherosclerosis
Volume245
DOIs
StatePublished - Feb 1 2016

Bibliographical note

Funding Information:
The authors have received funding from the NIH for the investigation of vitamin D and cardiovascular outcomes. This work is supported by grants from NIH/NINDS ( R01NS072243 to Dr. Michos), the NIH/NHLBI ( R01HL103706 to Dr. Lutsey), and the NIH Office of Dietary Supplements ( R01HL103706-S1 to Dr. Lutsey).

Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.

Keywords

  • Commentary
  • Coronary heart disease
  • Hypertension
  • Risk reclassification
  • Vitamin D

Cite this